Status:
RECRUITING
Pulsed RF Neuromodulation and Leukocyte-Rich PRP for Refractory Low Back Pain
Lead Sponsor:
Iffat Anwar Medical Complex
Conditions:
Multi-Organ Disorder
Eligibility:
All Genders
30-70 years
Phase:
EARLY_PHASE1
Brief Summary
This clinical trial aims to check the safety and efficacy profile of pulsed radiofrequency (RF) neuromodulation combined with leukocyte-rich platelet-rich plasma (PRP) injections for the treatment of ...
Detailed Description
Low back pain is a common condition, often associated with multifidus muscle dysfunction, which can result from aging, obesity, or limited movement. This dysfunction is characterized by fatty infiltra...
Eligibility Criteria
Inclusion
- Refractory low back pain due to multifidus dysfunction.
- Pain persisting for more than 6 months despite conventional treatments.
- Ability to provide informed consent.
Exclusion
- Previous spinal surgery within the last year.
- Current use of systemic steroids or immunosuppressive medications.
- Known bleeding disorders or anticoagulant therapy.
- Pregnancy or lactation.
- Severe psychiatric or cognitive disorders.
- Any Congenital or Non-congenital disorders
Key Trial Info
Start Date :
July 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06524531
Start Date
July 10 2024
End Date
December 30 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Iffat Anwar Medical Complex
Lahore, Punjab Province, Pakistan, 54000